Treatment of Chronic Idiopathic Cough (CIC) and Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis (IPF) with PA101

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 25 Sep 2017

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sodium cromoglicate (Primary)
Indications Cough
Focus Proof of concept; Therapeutic Use
Sponsors Patara Pharma

Most Recent Events

21 Sep 2017 According to a Patara Pharma media release, data were published in The Lancet Respiratory Medicine.
24 May 2017 Results presented at the 113th International Conference of the American Thoracic Society
07 Sep 2016 Primary endpoint has been met. (cough frequency), as reported by a Patara Pharma media release.

Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

IP authentication when working within your organization’s network.
Login with username/password or try access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days.
Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Contact your organization’s admin about adding this content to your AdisInsight subscription
Buy a PDF version of the profile.
Request a free trial

Welcome to AdisInsight